Navigation Links
Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.
Date:10/16/2008

COPENHAGEN, October 16 /PRNewswire-FirstCall/ -- Exiqon today announces the adoption of the name Exiqon Diagnostics for its U.S. subsidiary to signal the company's commitment to expanding its business to a broad offering in molecular and cellular-based diagnostics that guide treatment decisions in oncology.

Exiqon is pleased to announce the adoption of a new name for their clinical laboratory diagnostics business, Exiqon Diagnostics. This progressive change will demonstrate the continuity of the entire Exiqon organization and is an important symbol of Exiqon's commitment to transform Oncotech from its leading position in chemotherapy resistance testing to being the leader in personalized cancer diagnostics with a broad menu of molecular and cellular based assays for solid tumor diagnostics.

"We are excited to adopt this name for our business as it will show to our customers and their patients that Oncotech is undergoing a positive transformation that will lead to a more valuable and comprehensive offering," commented Lars Kongsbak, President and CEO of Exiqon A/S.

Since the acquisition, Exiqon has been integrating Oncotech and Exiqon to form "One Company" with multiple business divisions. Oncotech represents Exiqon's diagnostics division and as part of this integration plan, Exiqon is adopting the new name to better reflect this role within the company. The Oncotech name will continue to remain visible through the re-branding of the Extreme Drug Resistance assay as the Oncotech EDR Assay. As Exiqon Diagnostics, the business unit will be leveraging the broad and powerful intellectual property and R&D pipeline from Exiqon to establish a menu of innovative diagnostic tests that guide physicians in selecting the most appropriate therapies for their patients.

Going forward, Exiqon will create a parallel nomenclature for its three revenue driving businesses: our diagnostic business will conduct its business under the name Exiqon Diagnost
'/>"/>

SOURCE Exiqon A/S
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
2. Report Regarding the Managements and Closely Related Parties Transactions With Securities in Exiqon A/S
3. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
4. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
5. Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer
6. Exiqon: Major Shareholder Announcement
7. Vasogen Announces Third Quarter 2008 Results
8. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
9. SourceSolution Announces the Launch of Its Initiative to Simplify Outsourcing Decisions for Biotechnology and Pharmaceutical Companies
10. Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services
11. Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswire...nce Officer at Shenzhen Beike Biotechnology Co. Lt...nference on High-Risk Diabetic,Foot Care in New De...ading,stem cell research and regenerative medicine...the Indian Podiatry Association (IPA), aimed,to he...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportli...rt is available in its catalogue: ,, Carbondio..., http://www.reportlinker.com/p0164368/Carbondio... ,, Incubators are the most critical equipmen..., and other applications for providing a controlle...
(Date:12/2/2009)..., TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCall/... ) today reported completion of patient enrollment...ara® in patients with relapsed glioblastoma m...r. Cotara is a targeted monoclonal antibody linke... new treatment for GBM. Cotara specifically targe...
(Date:12/2/2009)... , CAMBRIDGE, Mass., Dec. 2 T...eaders in technology development and product integ...nnounced the December 11th deadline for technology...n its 14th year, TechConnect World, in association...STI), and the Clean Technology and Sustainable Ind...
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...ts Between Understanding Cholesterol Monitoring ...evels, PARSIPPANY, N.J., Sept. 4, 2007 A recent ... that in spite of concerns about the,serious healt...eart attack,stroke and coronary heart disease, the...ng what should be done to monitor and control high...
...ined With Radiation Reduced Tumor Growth by ... - Findings Confirm Key Aspects of Bavituximab,s ...n with Radiation Therapy -, - Results Further Sup... Combination With Radiation Thera...uticals, Inc. (Nasdaq: PPHM ), a clinical stage b...
...mion Corporation,(Nasdaq: PHRM ) today announced ...dent and chief financial officer, will present a c...are Conference in New York. The presentation will...mber 10, 2007 at the Grand Hyatt Hotel in New York...tation from the conference.,The webcast will be av...
Other Biology Technology:New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition 2New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition 3New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition 4New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition 5New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition 6New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition 7Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 2Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 3Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 4Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 5
(Date:12/3/2009)...ILADELPHIA Now in its 32nd year, the CTRC-AACR Sa...ract the best in breast cancer science and world l... eradicating breast cancer. , This year, more t...gather at the Henry B. Gonzales Convention Center ... is a partnership between the American Association...
(Date:12/3/2009)...rest dwellers must be included in the design of th...void a humanitarian crisis, according to a scienti...in Nature , Dr Simon Lewis argues that at least 5...openhagen, known as REDD (Reducing Emissions from ...forest dwellers directly, and their property right...
(Date:12/2/2009)...PHILADELPHIA Children exposed to secondhand cigar...ng cancer in adulthood, even if they never smoked....er Epidemiology, Biomarkers & Prevention , a journ..., as part of a special tobacco focus in the Decemb...Americans will be diagnosed with lung cancer; more...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Karmanos Cancer Institute Immunology Researcher Obtains Nearly 241 Million National Institutes of Health Grant 59855 1Karmanos Cancer Institute Immunology Researcher Obtains Nearly 241 Million National Institutes of Health Grant 59855 2Karmanos Cancer Institute Immunology Researcher Obtains Nearly 241 Million National Institutes of Health Grant 59855 3Stryker Operating Results for Quarter Ended September 30 2009 5619 1Stryker Operating Results for Quarter Ended September 30 2009 5619 2Stryker Operating Results for Quarter Ended September 30 2009 5619 3Stryker Operating Results for Quarter Ended September 30 2009 5619 4Stryker Operating Results for Quarter Ended September 30 2009 5619 5Stryker Operating Results for Quarter Ended September 30 2009 5619 6Stryker Operating Results for Quarter Ended September 30 2009 5619 7Stryker Operating Results for Quarter Ended September 30 2009 5619 8Stryker Operating Results for Quarter Ended September 30 2009 5619 9Stryker Operating Results for Quarter Ended September 30 2009 5619 10Aware Inc Reports Third Quarter 2009 Financial Results 10445 1Aware Inc Reports Third Quarter 2009 Financial Results 10445 2Aware Inc Reports Third Quarter 2009 Financial Results 10445 3Aware Inc Reports Third Quarter 2009 Financial Results 10445 4Aware Inc Reports Third Quarter 2009 Financial Results 10445 5Aware Inc Reports Third Quarter 2009 Financial Results 10445 6Aware Inc Reports Third Quarter 2009 Financial Results 10445 7
...fficulty of developing an AIDS vaccine, UCLA AIDS ... two HIV-positive identical twins responded to the...c. 5 issue of the peer-reviewed Journal of Virolog...he body,s defenses against the virus are random ra...rs followed the cases of male twins who were infec...
...e United States by spending less money on making m...ing treatments to the patients who need them, acco...lth University family medicine and public health p...ational Institutes of Health to develop blockbuste...hat Americans actually receive them," said Steven ...
...ed effort to catalogue all the molecular component...d ions to the genetic code. , These ,parts lists,...living processes. By combining models of simple pr...resent how entire biological systems - be they cel... As well as contributing to the understanding of b...
Other Biology News:UCLA scientists discover immune response to HIV differs, even in identical twins 2Access to existing medical treatments could save more lives than spending to improve the treatments 2Access to existing medical treatments could save more lives than spending to improve the treatments 3Setting the standard for computer models of life 2
...stem automates the denaturation and hybridization ...es walk-away convenience for clinical and research... of sample types, is easy to use, and reduces hand...precision and accuracy in all (F)ISH assays. Elimi...
...) is a fluorescent nucleic acid dye which binds on... counterstain, propidium iodide stains the nucleus...color provides excellent contrast to green or blue...um Iodide can be used for fluorescent in situ hybr...
...ls were cultured in DMEM with 4 mM L-glutamine med...order to keep the antigens in their native forms, ...re arrayed on a 12-well (5 mm) adhesive coated sli...o enhance cellular attachment and to minimize back...
...e cultured in DMEM and harvested at the log phase ... native forms, cells were fixed in acetone-methano...sive coated slide, with each wells surface specifi...o minimize background staining. Each well is load...
Biology Products: